- Home
- VRAR vs UG Comparison
VRAR vs UG Comparison
Compare VRAR & UG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRAR
- UG
- Stock Information
- Founded
- VRAR 2016
- UG 1942
- Country
- VRAR United States
- UG United States
- Employees
- VRAR N/A
- UG N/A
- Industry
- VRAR Retail: Computer Software & Peripheral Equipment
- UG Package Goods/Cosmetics
- Sector
- VRAR Technology
- UG Consumer Discretionary
- Exchange
- VRAR Nasdaq
- UG Nasdaq
- Market Cap
- VRAR 42.4M
- UG 50.1M
- IPO Year
- VRAR 2021
- UG N/A
- Fundamental
- Price
- VRAR $1.55
- UG $10.50
- Analyst Decision
- VRAR Strong Buy
- UG
- Analyst Count
- VRAR 1
- UG 0
- Target Price
- VRAR $4.67
- UG N/A
- AVG Volume (30 Days)
- VRAR 316.7K
- UG 8.6K
- Earning Date
- VRAR 02-13-2025
- UG 03-21-2025
- Dividend Yield
- VRAR N/A
- UG 6.67%
- EPS Growth
- VRAR N/A
- UG 38.11
- EPS
- VRAR N/A
- UG 0.76
- Revenue
- VRAR $9,230,197.00
- UG $12,312,275.00
- Revenue This Year
- VRAR $39.02
- UG N/A
- Revenue Next Year
- VRAR N/A
- UG N/A
- P/E Ratio
- VRAR N/A
- UG $13.84
- Revenue Growth
- VRAR N/A
- UG 11.51
- 52 Week Low
- VRAR $0.50
- UG $7.02
- 52 Week High
- VRAR $7.00
- UG $16.25
- Technical
- Relative Strength Index (RSI)
- VRAR 39.84
- UG 44.74
- Support Level
- VRAR $1.55
- UG $10.31
- Resistance Level
- VRAR $1.73
- UG $11.08
- Average True Range (ATR)
- VRAR 0.18
- UG 0.38
- MACD
- VRAR -0.01
- UG -0.07
- Stochastic Oscillator
- VRAR 10.58
- UG 23.85
About VRAR The Glimpse Group Inc.
The Glimpse Group Inc is a diversified Virtual and Augmented Reality platform company, comprised of multiple VR and AR software and services companies, and designed with the specific purpose of cultivating companies in the emerging VR/AR industry.
About UG United-Guardian Inc.
United-Guardian Inc manufactures and markets cosmetic ingredients, pharmaceuticals, medical lubricants, and specialty industrial products. Its product portfolio includes Klensoft, Deselex, Renacidin, Lubrajel Fluid. The company's pharmaceutical products are sold to and distributed by full-line drug wholesalers throughout the United States. Its medical and specialty industrial products are sold directly by the company to the end-users of those products or, in some cases, to contract manufacturers used by some of those end users. It operates in one business segment and its current product lines are separated into four distinct product categories that are cosmetic ingredients, pharmaceuticals, medical lubricants and sexual wellness. It derives key revenue from the sales made in the U.S.